| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytidine deaminase activity | 1.25e-05 | 13 | 72 | 3 | GO:0004126 | |
| GeneOntologyMolecularFunction | inositol 1,3,4,5 tetrakisphosphate binding | 1.27e-04 | 5 | 72 | 2 | GO:0043533 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 2.20e-04 | 82 | 72 | 4 | GO:1990756 | |
| GeneOntologyMolecularFunction | deaminase activity | 2.48e-04 | 34 | 72 | 3 | GO:0019239 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 2.95e-04 | 36 | 72 | 3 | GO:0016814 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 3.86e-04 | 95 | 72 | 4 | GO:0140767 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 5.75e-04 | 187 | 72 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 8.89e-04 | 206 | 72 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.03e-03 | 55 | 72 | 3 | GO:0042974 | |
| GeneOntologyBiologicalProcess | negative regulation of viral genome replication | 1.21e-06 | 56 | 69 | 5 | GO:0045071 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 4.23e-06 | 10 | 69 | 3 | GO:0070383 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 7.71e-06 | 12 | 69 | 3 | GO:0016554 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 1.27e-05 | 14 | 69 | 3 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 1.27e-05 | 14 | 69 | 3 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 1.27e-05 | 14 | 69 | 3 | GO:0009972 | |
| GeneOntologyBiologicalProcess | DNA deamination | 1.27e-05 | 14 | 69 | 3 | GO:0045006 | |
| GeneOntologyBiologicalProcess | regulation of viral genome replication | 1.35e-05 | 91 | 69 | 5 | GO:0045069 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1.94e-05 | 16 | 69 | 3 | GO:0045869 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 1.94e-05 | 16 | 69 | 3 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 1.94e-05 | 16 | 69 | 3 | GO:0046133 | |
| GeneOntologyBiologicalProcess | negative regulation of viral process | 2.46e-05 | 103 | 69 | 5 | GO:0048525 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 2.82e-05 | 18 | 69 | 3 | GO:0046135 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 3.34e-05 | 19 | 69 | 3 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 3.34e-05 | 19 | 69 | 3 | GO:0016553 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 3.92e-05 | 20 | 69 | 3 | GO:0039692 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 8.82e-05 | 26 | 69 | 3 | GO:0042454 | |
| GeneOntologyBiologicalProcess | viral genome replication | 9.60e-05 | 137 | 69 | 5 | GO:0019079 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside metabolic process | 9.89e-05 | 27 | 69 | 3 | GO:0006213 | |
| GeneOntologyBiologicalProcess | defense response to virus | 1.45e-04 | 342 | 69 | 7 | GO:0051607 | |
| GeneOntologyBiologicalProcess | DNA modification | 1.51e-04 | 31 | 69 | 3 | GO:0006304 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 1.64e-04 | 6 | 69 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 1.64e-04 | 6 | 69 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | viral RNA genome replication | 1.66e-04 | 32 | 69 | 3 | GO:0039694 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 1.66e-04 | 32 | 69 | 3 | GO:0009164 | |
| GeneOntologyBiologicalProcess | regulation of viral life cycle | 1.77e-04 | 156 | 69 | 5 | GO:1903900 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule catabolic process | 2.57e-04 | 37 | 69 | 3 | GO:0034656 | |
| GeneOntologyBiologicalProcess | glycosyl compound catabolic process | 3.49e-04 | 41 | 69 | 3 | GO:1901658 | |
| GeneOntologyBiologicalProcess | regulation of viral process | 3.98e-04 | 186 | 69 | 5 | GO:0050792 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 4.91e-04 | 46 | 69 | 3 | GO:0072529 | |
| GeneOntologyBiologicalProcess | response to virus | 5.39e-04 | 425 | 69 | 7 | GO:0009615 | |
| GeneOntologyBiologicalProcess | ribonucleoside metabolic process | 5.56e-04 | 48 | 69 | 3 | GO:0009119 | |
| GeneOntologyBiologicalProcess | innate immune response | TRIM49 TRAF3 APOBEC3D RSAD2 HLA-B WFDC11 TRIM49C OAS2 SKP2 TRIM49B APOBEC3B | 9.42e-04 | 1092 | 69 | 11 | GO:0045087 |
| GeneOntologyBiologicalProcess | defense response to symbiont | TRIM49 TRAF3 APOBEC3D RSAD2 HLA-B AICDA WFDC11 TRIM49C OAS2 SKP2 TRIM49B APOBEC3B | 1.06e-03 | 1286 | 69 | 12 | GO:0140546 |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 2.52e-05 | 352 | 71 | 8 | GO:0000151 | |
| GeneOntologyCellularComponent | transferase complex | TRAF3 FBXO8 EPOP LMO7 PRAMEF14 PRAMEF1 SKP2 PRAMEF13 CXXC1 METTL14 CBX2 | 3.80e-04 | 963 | 71 | 11 | GO:1990234 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 5.47e-04 | 47 | 71 | 3 | GO:0031462 | |
| Domain | APOBEC_N | 9.92e-06 | 12 | 68 | 3 | PF08210 | |
| Domain | APOBEC_N | 9.92e-06 | 12 | 68 | 3 | IPR013158 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.63e-05 | 14 | 68 | 3 | IPR016192 | |
| Domain | Cytidine_deaminase-like | 3.03e-05 | 17 | 68 | 3 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 3.03e-05 | 17 | 68 | 3 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 3.03e-05 | 17 | 68 | 3 | IPR002125 | |
| Domain | DysFC | 7.80e-05 | 4 | 68 | 2 | SM00694 | |
| Domain | DysFN | 7.80e-05 | 4 | 68 | 2 | SM00693 | |
| Domain | Peroxin/Ferlin | 7.80e-05 | 4 | 68 | 2 | IPR006614 | |
| Domain | AT_hook | 1.27e-04 | 27 | 68 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.27e-04 | 27 | 68 | 3 | IPR017956 | |
| Domain | ArfGap | 1.58e-04 | 29 | 68 | 3 | SM00105 | |
| Domain | ArfGap | 1.58e-04 | 29 | 68 | 3 | PF01412 | |
| Domain | ARFGAP | 1.58e-04 | 29 | 68 | 3 | PS50115 | |
| Domain | ArfGAP | 1.58e-04 | 29 | 68 | 3 | IPR001164 | |
| Domain | PH_DOMAIN | 5.30e-04 | 279 | 68 | 6 | PS50003 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 1.33e-03 | 15 | 68 | 2 | PS51747 | |
| Domain | Znf_RING/FYVE/PHD | 1.38e-03 | 459 | 68 | 7 | IPR013083 | |
| Domain | BBOX | 2.04e-03 | 69 | 68 | 3 | SM00336 | |
| Domain | Butyrophylin | 2.12e-03 | 70 | 68 | 3 | IPR003879 | |
| Domain | PRAME_family | 2.15e-03 | 19 | 68 | 2 | IPR026271 | |
| Domain | - | 2.21e-03 | 71 | 68 | 3 | 4.10.45.10 | |
| Domain | zf-B_box | 2.30e-03 | 72 | 68 | 3 | PF00643 | |
| Domain | - | 2.97e-03 | 391 | 68 | 6 | 2.30.29.30 | |
| Domain | ZF_BBOX | 3.10e-03 | 80 | 68 | 3 | PS50119 | |
| Domain | Znf_B-box | 3.22e-03 | 81 | 68 | 3 | IPR000315 | |
| Domain | PH | 3.42e-03 | 278 | 68 | 5 | SM00233 | |
| Domain | PH_domain | 3.53e-03 | 280 | 68 | 5 | IPR001849 | |
| Domain | HR1_rho-bd | 3.71e-03 | 25 | 68 | 2 | IPR011072 | |
| Domain | SPRY | 3.93e-03 | 87 | 68 | 3 | SM00449 | |
| Domain | PH_dom-like | 4.52e-03 | 426 | 68 | 6 | IPR011993 | |
| Domain | ETS_DOMAIN_1 | 4.64e-03 | 28 | 68 | 2 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 4.64e-03 | 28 | 68 | 2 | PS00346 | |
| Domain | ETS | 4.64e-03 | 28 | 68 | 2 | SM00413 | |
| Domain | Ets_dom | 4.64e-03 | 28 | 68 | 2 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 4.64e-03 | 28 | 68 | 2 | PS50061 | |
| Domain | Ets | 4.64e-03 | 28 | 68 | 2 | PF00178 | |
| Domain | SPRY | 4.88e-03 | 94 | 68 | 3 | PF00622 | |
| Domain | SPRY_dom | 4.88e-03 | 94 | 68 | 3 | IPR003877 | |
| Domain | B30.2/SPRY | 5.03e-03 | 95 | 68 | 3 | IPR001870 | |
| Domain | B302_SPRY | 5.03e-03 | 95 | 68 | 3 | PS50188 | |
| Domain | HMGI/Y_DNA-bd_CS | 5.67e-03 | 31 | 68 | 2 | IPR000637 | |
| Domain | - | 5.82e-03 | 449 | 68 | 6 | 3.30.40.10 | |
| Domain | - | 7.19e-03 | 35 | 68 | 2 | 3.20.20.80 | |
| Pubmed | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. | 3.40e-08 | 4 | 72 | 3 | 24821801 | |
| Pubmed | Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils. | 3.40e-08 | 4 | 72 | 3 | 29343743 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 21659520 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 2.44e-07 | 26 | 72 | 4 | 18500982 | |
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 12683974 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 19703589 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 14690521 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12018390 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22446380 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 5.32e-06 | 55 | 72 | 4 | 19468303 | |
| Pubmed | 6.79e-06 | 18 | 72 | 3 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 6.79e-06 | 18 | 72 | 3 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 6.79e-06 | 18 | 72 | 3 | 29731491 | |
| Pubmed | 6.79e-06 | 18 | 72 | 3 | 14675769 | ||
| Pubmed | Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope. | 6.79e-06 | 18 | 72 | 3 | 37914931 | |
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 8.05e-06 | 19 | 72 | 3 | 22144910 | |
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 8.05e-06 | 19 | 72 | 3 | 28604677 | |
| Pubmed | 9.46e-06 | 20 | 72 | 3 | 26694250 | ||
| Pubmed | 9.46e-06 | 20 | 72 | 3 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 9.46e-06 | 20 | 72 | 3 | 21425410 | |
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 1.27e-05 | 3 | 72 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 1.27e-05 | 3 | 72 | 2 | 27602762 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 1.27e-05 | 3 | 72 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 1.27e-05 | 3 | 72 | 2 | 24577894 | |
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 1.27e-05 | 3 | 72 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 1.27e-05 | 3 | 72 | 2 | 23533681 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 1541833 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 27356895 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 23315078 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 1.27e-05 | 3 | 72 | 2 | 25589647 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 1.27e-05 | 3 | 72 | 2 | 31518043 | |
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 1.27e-05 | 3 | 72 | 2 | 24840555 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 9765497 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 24453360 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 23449789 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 1.27e-05 | 3 | 72 | 2 | 18434399 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 1.27e-05 | 3 | 72 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 1.27e-05 | 3 | 72 | 2 | 18772436 | |
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 1.27e-05 | 3 | 72 | 2 | 18786991 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 286744 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 24725948 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 20702647 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 20980520 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 284359 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 20617165 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 1.27e-05 | 3 | 72 | 2 | 39208378 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 31943071 | ||
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 1.27e-05 | 3 | 72 | 2 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 1.27e-05 | 3 | 72 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 1.27e-05 | 3 | 72 | 2 | 25505062 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 31595054 | ||
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 1.27e-05 | 3 | 72 | 2 | 17967065 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 20335265 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 1.27e-05 | 3 | 72 | 2 | 29593034 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 31830125 | ||
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 1.27e-05 | 3 | 72 | 2 | 21998583 | |
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 1.27e-05 | 3 | 72 | 2 | 38115583 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 1.27e-05 | 3 | 72 | 2 | 35458563 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 22275865 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 293683 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 19150103 | ||
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 1.27e-05 | 3 | 72 | 2 | 12466850 | |
| Pubmed | 1.27e-05 | 22 | 72 | 3 | 31729367 | ||
| Pubmed | 1.46e-05 | 23 | 72 | 3 | 19480014 | ||
| Pubmed | 1.67e-05 | 24 | 72 | 3 | 23920106 | ||
| Pubmed | 1.89e-05 | 25 | 72 | 3 | 37451217 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 1.89e-05 | 25 | 72 | 3 | 12620990 | |
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 2.53e-05 | 4 | 72 | 2 | 18983852 | |
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 2.53e-05 | 4 | 72 | 2 | 31400166 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 23725696 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 21985787 | ||
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 2.53e-05 | 4 | 72 | 2 | 25355878 | |
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 2.53e-05 | 4 | 72 | 2 | 26253512 | |
| Pubmed | Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. | 2.53e-05 | 4 | 72 | 2 | 17020885 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 20375169 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 21147467 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 16055735 | ||
| Pubmed | The incorporation of APOBEC3 proteins into murine leukemia viruses. | 2.53e-05 | 4 | 72 | 2 | 18572219 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 16378963 | ||
| Pubmed | Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s. | 2.53e-05 | 4 | 72 | 2 | 32893454 | |
| Pubmed | Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. | 2.53e-05 | 4 | 72 | 2 | 15269786 | |
| Pubmed | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. | 2.53e-05 | 4 | 72 | 2 | 20363737 | |
| Pubmed | APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | 2.53e-05 | 4 | 72 | 2 | 15674295 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 21873525 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 25501566 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 18702815 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 20538015 | ||
| Pubmed | The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | 2.53e-05 | 4 | 72 | 2 | 38049664 | |
| Pubmed | Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. | 2.53e-05 | 4 | 72 | 2 | 26846717 | |
| Pubmed | Vaccinia virus replication is not affected by APOBEC3 family members. | 2.53e-05 | 4 | 72 | 2 | 17052331 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 28415995 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 9223268 | ||
| Pubmed | Species-specific restriction of apobec3-mediated hypermutation. | 2.53e-05 | 4 | 72 | 2 | 18032489 | |
| Pubmed | Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. | 2.53e-05 | 4 | 72 | 2 | 25303118 | |
| Pubmed | APOBEC3 inhibits mouse mammary tumour virus replication in vivo. | 2.53e-05 | 4 | 72 | 2 | 17259974 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 23555255 | ||
| Cytoband | 1p36.21 | 1.37e-04 | 63 | 72 | 3 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 7.10e-04 | 681 | 72 | 6 | chr1p36 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 4.85e-06 | 12 | 52 | 3 | 406 | |
| GeneFamily | PRAME family | 4.35e-05 | 24 | 52 | 3 | 686 | |
| GeneFamily | ArfGAPs | 1.15e-04 | 33 | 52 | 3 | 395 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.08e-04 | 206 | 52 | 5 | 682 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.58e-03 | 95 | 52 | 3 | 59 | |
| GeneFamily | ETS transcription factor family | 2.92e-03 | 28 | 52 | 2 | 534 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-09 | 142 | 72 | 7 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-09 | 142 | 72 | 7 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-06 | 149 | 72 | 5 | a464c0fd54e3c9e1d40d95b49489cb9371dd7c24 | |
| ToppCell | Monocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.79e-06 | 176 | 72 | 5 | 6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 184 | 72 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 185 | 72 | 5 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 195 | 72 | 5 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | C_05|World / shred on cell type and cluster | 1.65e-05 | 196 | 72 | 5 | bf4dfb460a153dbafb2b9b12b360c8757cec22cd | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 197 | 72 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 197 | 72 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.69e-05 | 197 | 72 | 5 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 1.81e-05 | 200 | 72 | 5 | 09deb831fc2c8a8867cc850f3aa094a5e48489ff | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-05 | 200 | 72 | 5 | 3f29823952a4303451997dd5177a51179bd20540 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-05 | 200 | 72 | 5 | b2fa6e44ace5897766792ed97ffafc11555175e7 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.22e-05 | 146 | 72 | 4 | 26493014daa432db721613ef480d133f3da9eb58 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 158 | 72 | 4 | b35bab2b93d0af821bfae18a358eb7dddaf3860f | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 158 | 72 | 4 | 7bd4a64a610eb1cbcd3d07ea5258a55107cf6c00 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 160 | 72 | 4 | b2d8940ea8c068273b7da1589d3d6ae5110d8209 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-04 | 160 | 72 | 4 | 913e59cecf3b1bdd1ef32b4e320042b9bbdb54bc | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 160 | 72 | 4 | 9caab1bb63c7e66c44783852ee75b16bb40fa594 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 160 | 72 | 4 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 160 | 72 | 4 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 160 | 72 | 4 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 160 | 72 | 4 | 229841be7b984a00a301cd5d88c11226a90d8a88 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 160 | 72 | 4 | 99c9ae2041445539fada842e1af01368669bfca0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 166 | 72 | 4 | 82fa07632f7e586698fbf37381715b40f9f6ae3a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 166 | 72 | 4 | 0d03926452414f232c77fd15d5f48d148f9fca3b | |
| ToppCell | ASK454-Epithelial-Transformed_epithelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.73e-04 | 172 | 72 | 4 | 3986f0f098ef5e096c8d9ee3d335b8404083701f | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 173 | 72 | 4 | 766e712e4db440468a32971459c1d3354add611f | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 173 | 72 | 4 | 40ef91afb366e87b5ba2951d2578ebfe04d042c0 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|normal_Lung / Location, Cell class and cell subclass | 1.89e-04 | 176 | 72 | 4 | f31d7234053085a82cf9d55aeedd1e04d34789c3 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 178 | 72 | 4 | 4289e435d465b7a1490d13bf05278f4ed77d69cd | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-04 | 182 | 72 | 4 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 183 | 72 | 4 | 7eaa6ef7c6cf848fd6489f97677f4406318da22f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 184 | 72 | 4 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 184 | 72 | 4 | 5b0695b1fbc8e4230f8f0669373ea10af82a0130 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 2.24e-04 | 184 | 72 | 4 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 184 | 72 | 4 | 6485d0d34bdab337b747c0ea2d75e8fad8486b4d | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 2.24e-04 | 184 | 72 | 4 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-04 | 185 | 72 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | PBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 2.29e-04 | 185 | 72 | 4 | 4b5a7450fed912f340da16065c1e65d626dbe8d1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 186 | 72 | 4 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.38e-04 | 187 | 72 | 4 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | c21e7904e06a5c90176f935f6822dbb5a1aa6755 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-04 | 191 | 72 | 4 | b7713aba839e7a1f548b7b9d8893067bcc6d7ee7 | |
| ToppCell | E17.5-Epithelial-epithelial_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-04 | 191 | 72 | 4 | 68b717fce7d9349ef56255ee0c5e57fc67e50fd8 | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 2.64e-04 | 192 | 72 | 4 | be9d5685fa03563322f147a4b38ed31e4da59487 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.64e-04 | 192 | 72 | 4 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 192 | 72 | 4 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-04 | 193 | 72 | 4 | 32eb026d4317c1499d51294d396dfd5f293f9deb | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.69e-04 | 193 | 72 | 4 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-04 | 193 | 72 | 4 | 930df79b0600f43617052313294be33bcf5631f0 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 2.69e-04 | 193 | 72 | 4 | c0d4da15d973cf6f8daa2b0af84b1baaf8491b83 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-04 | 194 | 72 | 4 | 07d8e38cbc2c7f0564c14f7c365f345f901b73b2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 194 | 72 | 4 | c578cf7c6b4d6f31f87dde8845de5b3891f16822 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 194 | 72 | 4 | f4286ae7bb8350c42d50727ee8688b80129714f6 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.74e-04 | 194 | 72 | 4 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 194 | 72 | 4 | 79baee8b35b7707bbeb07c73b5e17b68bcd7bbc2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 194 | 72 | 4 | f6e348f1f35c526cad6c349f1fdd0bd92d18aa3c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 194 | 72 | 4 | 87461bd6d7f702c0a0f5e0c8ace3049125a51f9a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 194 | 72 | 4 | 715e02e5f3250b1bfdc26b7dfd656ba4e705ea84 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 194 | 72 | 4 | ce599ed0dc181aea0584e426636de5098f34ebe6 | |
| ToppCell | moderate-Epithelial-IRC-IFNG_responsive_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.80e-04 | 195 | 72 | 4 | 4ea79451b9c040650a74831b64a41d36b180ac0f | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 2.80e-04 | 195 | 72 | 4 | c3280bb6219e2eff5e24ef45aa2d76479a562122 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.80e-04 | 195 | 72 | 4 | b6bf75669f267ecdc96818c7022db852e37a9fe1 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 195 | 72 | 4 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 195 | 72 | 4 | 18220efbd2d6ce6aa7501744fe430b6b46f2fc30 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 2.85e-04 | 196 | 72 | 4 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.85e-04 | 196 | 72 | 4 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.85e-04 | 196 | 72 | 4 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | mild-Myeloid-Neutrophils_4|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.85e-04 | 196 | 72 | 4 | f8c98cded5550843322b1711e1a57c7e88cae861 | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 2.85e-04 | 196 | 72 | 4 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | mild-Myeloid-Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.85e-04 | 196 | 72 | 4 | e9f30eb8a3915c3b2af009c832bff9b349b65ae5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-04 | 196 | 72 | 4 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 197 | 72 | 4 | a6a27e5809ee2c9b56c7e06c35e4f140f9fa13ad | |
| ToppCell | NS-moderate-d_16-33-Epithelial-IRC-IFNG_responsive_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.91e-04 | 197 | 72 | 4 | 8eda7d5a44b18c805c963235aea794e9223d1ac0 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 197 | 72 | 4 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 197 | 72 | 4 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | 390C-Myeloid-Dendritic|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 197 | 72 | 4 | 424526c94b9a73c1c28ddc65dfba53aba5c6b2d2 | |
| ToppCell | Transverse-T_cell-cycling_gd_T|Transverse / Region, Cell class and subclass | 2.96e-04 | 198 | 72 | 4 | 5131b0b7d6c4dd8872cef9f2e233f59f751b4690 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.96e-04 | 198 | 72 | 4 | cc808d872d2404a79ec119bb0be62688a30c93a7 | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 198 | 72 | 4 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 198 | 72 | 4 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | Transverse-(1)_T_cell-(18)_cycling_gd_T|Transverse / shred on region, Cell_type, and subtype | 2.96e-04 | 198 | 72 | 4 | 396dddf7ebad41c3a91329b6a280623c0dfdcd2f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-04 | 198 | 72 | 4 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 198 | 72 | 4 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 198 | 72 | 4 | 8fac96132663f54566136ef54b53684d31dfde32 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 198 | 72 | 4 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 198 | 72 | 4 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 198 | 72 | 4 | c48b3f026b16d48b8eca9f74dc1e3f3f39a89322 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 198 | 72 | 4 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-04 | 198 | 72 | 4 | f801157468e59b5d049f703feadc9bb0f11e85cc | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-04 | 199 | 72 | 4 | 043c65bdf54a1bf0e483fea9ffc042ff5b271764 | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.02e-04 | 199 | 72 | 4 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | 5'-Adult|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-04 | 199 | 72 | 4 | 8b7b1fcea9a06522fdfab85d0dfd33010ae96d75 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.02e-04 | 199 | 72 | 4 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.02e-04 | 199 | 72 | 4 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-04 | 199 | 72 | 4 | 0181c13379f869be47804cdb11bbdabcd30b9b23 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-04 | 199 | 72 | 4 | ee981046217e8759610eb58a670d98f32cd83abc | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.08e-04 | 200 | 72 | 4 | eac33be484dc443794e66e473f03e98406c2983e | |
| Disease | post-operative acute kidney injury, response to surgery | 7.35e-05 | 6 | 66 | 2 | EFO_0009951, EFO_0009955 | |
| Disease | 3-hydroxyphenylacetic acid measurement | 4.41e-04 | 14 | 66 | 2 | EFO_0010448 | |
| Disease | susceptibility to chronic sinus infection measurement | 4.83e-04 | 68 | 66 | 3 | EFO_0008419 | |
| Disease | perceived unattractiveness to mosquitos measurement | 5.71e-04 | 72 | 66 | 3 | EFO_0008380 | |
| Disease | Lung Injury | 1.01e-03 | 21 | 66 | 2 | C0273115 | |
| Disease | Chronic Lung Injury | 1.01e-03 | 21 | 66 | 2 | C2350344 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLRFKRRWSEDCRLE | 481 | P50548 | |
| WKYRVFLRDELCIKQ | 86 | B9A014 | |
| REGPCWRKRGYKTLL | 71 | Q9H172 | |
| GRLFRTKVWELYKQC | 316 | P46663 | |
| IRRVWQKRKCGVKYG | 316 | Q8TDY4 | |
| CYEVKIKRGRSNLLW | 36 | Q96AK3 | |
| DRILKDRRKKVIGWY | 81 | Q15018 | |
| CYEVKIKRGRSNLLW | 36 | Q9UH17 | |
| SYRKNKWIVEGRLRR | 1001 | Q9UIF9 | |
| VAKENVRKQWRRYLC | 881 | Q8IZP9 | |
| VRKQWRRYLCCGKLR | 886 | Q8IZP9 | |
| KNVRWAKGRRETYLC | 16 | Q9GZX7 | |
| IKQRKVLDLRRWYCI | 191 | Q86UB2 | |
| KRGRPRKLSKEYWDC | 246 | P78545 | |
| CQLLREQWIRAKYER | 101 | O75689 | |
| WCRRRKTTRLGKYPV | 356 | P51793 | |
| LVLKEQWIRAKYERR | 106 | Q9NPF8 | |
| SVCYRRKDLWKVSLR | 126 | Q9BQD7 | |
| LRRLKKYDNCWLALT | 66 | P35558 | |
| YLTDAKRRLRKVVWV | 531 | Q9ULE6 | |
| IRRQRLKGDAWVYKR | 626 | Q14680 | |
| ATVGRRYLWLKDCKI | 646 | P42166 | |
| KERVRWRTKQNLDYC | 236 | Q9UQ53 | |
| RRYLKLRAEWRCQVE | 1966 | Q9UKN7 | |
| LRQRLKCRSFKWYLE | 436 | Q9HCQ5 | |
| REYWRDRLLKLKACG | 101 | Q8NCI6 | |
| LDLGRVCLRKWGYRR | 241 | Q9HCE5 | |
| CTRTLNWKKLRIYLD | 176 | Q9NRD0 | |
| GWLYLRDRVCSKKDI | 46 | Q8WWI1 | |
| RCLDWNRDILKKELG | 546 | Q9Y2J8 | |
| DLIRLVKHWYKECER | 541 | P29728 | |
| WLRRYLENGKDKLER | 191 | P01889 | |
| VIIYNLTRLCRWDKR | 286 | Q96QZ0 | |
| RALKWREEQRKECYA | 471 | Q2TAC6 | |
| REWYCRECREKDPKL | 66 | Q9P0U4 | |
| RLRKGKLEYLVKWRG | 21 | Q14781 | |
| DRLIRRSKLWCYAKG | 246 | A6NHQ4 | |
| CRTQWYLRIDKRGKV | 71 | P21781 | |
| LWYVFCRDRKVLREG | 191 | P36268 | |
| SWPRLIRKLRCYLKE | 216 | Q5VWM6 | |
| RKDSERRAILYKILW | 1006 | Q6ZN16 | |
| RCWKDYVNLRLEAIR | 166 | P0CI25 | |
| KRRCGWLDLMILRYA | 336 | Q8N142 | |
| KENRRKWKRYLLIGL | 181 | Q5TGY1 | |
| KLRRWCRDYRVAFKI | 206 | Q8WXG1 | |
| RKPKRYELRCIIWKT | 1716 | A0AVI2 | |
| SWPRLIRKLRCYLKE | 216 | Q5SWL7 | |
| CKIKLWEVYGERRCL | 311 | O60508 | |
| SWPRLIRKLRCYLKE | 216 | O95521 | |
| AEIGRLWRKDKYDCL | 456 | P40879 | |
| IKKVQSFLRGWLCRR | 206 | Q13972 | |
| LVWLLIRRKDKERYE | 251 | Q9H6B4 | |
| RGCRRYRWELKDSNK | 66 | Q8TAZ6 | |
| ELLKVSGVCKRWYRL | 116 | Q13309 | |
| AAYVKRLCKGLSWRE | 16 | Q8TDR2 | |
| GVLIWKIRDYKRRKQ | 416 | Q13114 | |
| YCRRDVVDLKHKWRD | 176 | Q96NA8 | |
| RDWLREDVKRGCVYL | 21 | Q6ZVD8 | |
| LGLCAALYWRRKQRK | 906 | Q96MS0 | |
| KDFVRRRCWARKCKL | 906 | Q7Z6L1 | |
| RCWKDYVNLRLEAIR | 166 | P0CI26 | |
| RRRRKAIAEIWPKYC | 1156 | Q9H5I5 | |
| IPYLLGRKRRWSKCK | 846 | P55017 | |
| RRGLWEKCQEYLRKI | 496 | Q8N9R8 | |
| QWDRITRLEKGKIYR | 321 | Q9H857 | |
| LDKIDRRYAWIKRQL | 281 | Q5VIR6 | |
| LLRGLVQRWRYGKVC | 31 | Q969W1 | |
| YRWGLREKRAEVLKF | 871 | Q6PJI9 | |
| ERLLWRICRGNVYLK | 186 | Q9HBG4 | |
| SKYRKRECISGRQWE | 701 | Q63HK3 | |
| RCWKDYVNLRLEAIR | 166 | A6NDI0 | |
| RYDRKELLLEECWGK | 31 | Q8NEX6 | |
| RRELICWGDSVKLRY | 481 | P35573 |